Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

GSK-3beta controls osteogenesis through regulating Runx2 activity.

Fumitaka Kugimiya1, Hiroshi Kawaguchi, Shinsuke Ohba

  • 1Center for Disease Biology and Integrative Medicine, University of Tokyo, Tokyo, Japan.

Plos One
|September 6, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Late-onset polyvinylpyrrolidone allergy in a long-term hemodialysis patient: a case report of dialysis hypotension and gastrointestinal symptoms.

CEN case reports·2026
Same author

Stem cell therapy for spinal cord injury: lessons from Japan's experiment in regulatory deregulation.

The spine journal : official journal of the North American Spine Society·2026
Same author

Electromyographic Prediction of Walking Independence in Patients With Incomplete Spinal Cord Injury.

Archives of rehabilitation research and clinical translation·2026
Same author

Phantom for standardization in functional near-infrared spectroscopy, part 1: implementation and usage.

Neurophotonics·2025
Same author

Functional Near-Infrared Spectroscopy Reveals Functional Rewiring between Macaque Motor Areas Following Postinfarction Recovery of Manual Dexterity.

The Journal of neuroscience : the official journal of the Society for Neuroscience·2025
Same author

Evaluating the Impact of Linezolid Metabolites: PNU-142300 and PNU-142586 on the Development of Linezolid-Induced Thrombocytopenia in Adult Patients.

Journal of clinical pharmacology·2025
Same journal

Epidemiological characteristics of amebiasis in Japan from 2001 to 2022.

PloS one·2026
Same journal

Longitudinal associations of academic stress with eating related patterns, nutrition, somatic indicators, and depressive symptoms in university students: A study protocol.

PloS one·2026
Same journal

Pollution removal efficiency enhancement by agricultural biomass additions in constructed wetlands: A framework integrating meta-analysis with explainable machine learning.

PloS one·2026
Same journal

Insulation failure mapping on power transformer bushing using FRA and electrostatic simulation.

PloS one·2026
Same journal

Enhancing medical Q&A systems with multimodal knowledge graphs and dual-layer attention mechanisms.

PloS one·2026
Same journal

UAMP: Consistent video object segmentation with uncertainty-aware memory propagation.

PloS one·2026
See all related articles

Glycogen synthase kinase-3beta (GSK-3beta) deficiency enhances bone formation by boosting Runx2 activity. Inhibiting GSK-3beta may treat bone disorders like cleidocranial dysplasia.

Area of Science:

  • Bone biology and skeletal development
  • Molecular signaling pathways in osteogenesis
  • Genetic regulation of bone formation

Background:

  • Despite advances, the molecular mechanisms governing bone formation require further elucidation for clinical translation.
  • Understanding signaling pathways is crucial for developing treatments for bone disorders.
  • Runx2 is a key transcription factor in bone development, but its regulation is complex.

Purpose of the Study:

  • To investigate the role of glycogen synthase kinase-3beta (GSK-3beta) in regulating bone formation.
  • To determine if GSK-3beta influences the activity of the transcription factor Runx2.
  • To explore GSK-3beta as a potential therapeutic target for skeletal dysplasias.

Main Methods:

  • Utilized heterozygous GSK-3beta-deficient mice to study bone formation.

Related Experiment Videos

  • Assessed the transcriptional activity of Runx2 in the context of GSK-3beta deficiency.
  • Administered lithium chloride, a GSK-3beta inhibitor, to rescue cleidocranial dysplasia models.
  • Examined the effects of genetic GSK-3beta insufficiency on Runx2 phosphorylation.

    • Main Results:

    • Heterozygous GSK-3beta deficiency led to increased bone formation.
    • GSK-3beta deficiency enhanced Runx2 transcriptional activity by reducing inhibitory phosphorylation.
    • Genetic insufficiency of GSK-3beta or lithium chloride treatment rescued cleidocranial dysplasia phenotypes in Runx2-deficient mice.
    • GSK-3beta was identified as a key regulator of Runx2 activity.

    Conclusions:

    • GSK-3beta acts as a critical negative regulator of Runx2 activity in bone formation.
    • Targeting GSK-3beta offers a potential therapeutic strategy for bone catabolic disorders.
    • This study highlights GSK-3beta as a promising molecular target for treating conditions like cleidocranial dysplasia.